University of Genoa
Utility of nailfold video-capillaroscopy reviewed
Published in Healthcare Finance, Tax and Law Weekly, March 16th, 2005
"The Raynaud phenomenon (RP) is the most common and significant clinical condition supporting microvascular analysis as soon as possible," scientists in Italy explained. "Microvascular involvement is a key feature of RP, and several rheumatic diseases are characterized by the presence of the RP."
"Nailfold capillary microscopy shows an impressive cost/effectiveness ratio: it is simple, noninvasive and inexpensive," noted A. Cutolo and colleagues at the University of Genoa. "Well-recognized videocapillaro-scopic patterns (NVC) have been described...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AEterna Zentaris, Inc.
AEterna Zentaris subsidiary files preliminary prospectus for IPO - AFP Imaging Corporation
Imaging company reports record profitable second quarter - Abortion
Bill would require viewing graphic photos before abortion - Accentia Biopharmaceuticals, Inc.
Biopharmaceutical company reports plans for initial public offering - Advanced Neuromodulation Systems, Inc.
Medical device firm reports 26% increase in fourth quarter revenue - Advanced Nutraceuticals, Inc.
Nutraceutical company reports income of $0.08 per share - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
